1922 Organometallics, Vol. 29, No. 8, 2010
Liu et al.
3
(75 MHz, CDCl3, 25 ꢀC): δ 18.12 (2C, o-NC6H2Me3), 20.92
(1C, p-NC6H2Me3), 105.89, 114.50, 121.28, 127.63, 128.81
(5C, quinoline), 129.13 (2C, NC6H2Me3), 135.44 (1C, quino-
line), 135.62 (1C, NC6H2Me3), 135.97 (1C, quinoline), 136.43
(2C, NC6H2Me3), 137.96 (1C, NC6H2Me3), 143.08, 147.01 (2C,
quinoline).
4H, THF), 6.14 (d, JH-H = 7.8 Hz, 1H, quinoline), 6.79 (d,
3JH-H = 7.8 Hz, 1H, quinoline), 6.95 (q, 3JH-H = 4.8 Hz, 1H,
quinoline), 7.06 (t, 1H, 3JH-H = 7.8 Hz, NC6H3Me2), 7.17 (d,
3JH-H = 7.5 Hz, 2H, NC6H3Me2), 7.24 (t, 1H, 3JH-H = 8.1 Hz,
3
quinoline), 7.71 (d, JH-H = 8.1 Hz, 1H, quinoline), 9.13 (d,
3JH-H = 3.0 Hz, 1H, quinoline). 13C NMR (100 MHz, C6D6, 25
ꢀC): δ 4.27 (6C, SiMe3), 19.43 (2C, o-NC6H3Me2), 25.02 (2C,
THF), 41.65 (br, 2C, CH2SiMe3), 71.81 (2C, THF), 107.18,
111.51, 121.04 (3C, quinoline), 124.54 (1C, NC6H3Me2), 129.27
(2C, NC6H3Me2), 131.06, 131.16 (2C, quinoline), 135.31 (2C,
NC6H3Me2), 140.15 (1C, quinoline), 141.41 (1C, NC6H3Me2),
146.23, 149.12, 153.00 (3C, quinoline). Anal. Calcd for C29H45-
ScN2Si2 (%): C, 64.64; H, 8.42; N, 5.20. Found: C, 63.51; H,
8.19; N, 5.03.
N-(2,6-Diethylphenyl)quinolin-8-amine (HL3). Following the
same procedure described for the formation of HL1, treatment
of 2,6-diethylaniline (1.79 g, 12 mmol), Pd(OAc)2 (22 mg, 0.10
mmol), NatOBu (1.44 g,15 mmol), 8-bromoquinoline (2.08 g, 10
mmol), and bis[2-(diphenylphosphino)phenyl] ether (DPEphos,
1
80.8 mg, 0.15 mmol) gave HL3 (1.36 g, 49%). H NMR (300
MHz, CDCl3, 25 ꢀC): δ 1.15 (t, 3JH-H = 7.5 Hz, 6H, CH2CH3),
2.62 (br s, 4H, CH2CH3), 6.25 (dd, 3JH-H = 7.5 Hz, 4JH-H
=
1.2 Hz, 1H, quinoline), 7.08 (dd, 3JH-H = 8.1 Hz, 4JH-H = 1.2
Hz, 1H, quinoline), 7.21-7.27 (m, 4H, NC6H3Et2, quinoline),
7.42 (q, 3JH-H = 4.2 Hz, 1H, quinoline), 7.58 (br s, 1H, NH),
8.11 (dd, 3JH-H = 8.1 Hz, 4JH-H = 1.5 Hz, 1H, quinoline), 8.81
L2Sc(CH2SiMe3)2(THF) (2). Following a similar procedure
to that described for the preparation of 1, the reaction of
Sc(CH2SiMe3)3(THF)2 (0.18 g, 0.4 mmol in 3 mL of hexane)
with equimolar HL2 (0.12 g, 0.4 mmol in 4 mL of hexane) gave 2
(0.18 g, 82%). 1H NMR (300 MHz, C6D6, 25 ꢀC): δ 0.15, 0.40
(AB, 2JH-H = 11.4 Hz, 4H, CH2SiMe3), 0.26 (s, 18H, SiMe3),
1.13 (br, 4H, THF), 2.31 (s, 6H, o-NC6H2Me3), 2.34 (s, 3H,
p-NC6H2Me3), 3.73 (br, 4H, THF), 6.16 (dd, 3JH-H = 7.8 Hz,
3
4
(dd, JH-H = 4.2 Hz, JH-H = 1.8 Hz, 1H, quinoline). 13C
NMR (75 MHz, CDCl3, 25 ꢀC): δ 14.88 (2C, CH2CH3), 24.73
(2C, CH2CH3), 106.00, 114.51, 121.32 (3C, quinoline), 126.63
(2C, NC6H3Et2), 126.79 (1C, NC6H3Et2), 127.58, 128.75,
135.97, 136.92 (4C, quinoline), 137.81 (1C, NC6H3Et2), 142.88
(2C, NC6H3Et2), 143.79, 147.06 (2C, quinoline).
4JH-H = 0.9 Hz, 1H, quinoline), 6.79 (dd, JH-H = 8.1 Hz,
3
4JH-H = 0.9 Hz, 1H, quinoline), 6.95-6.99 (m, 3H, m-NC6H2-
Me3, quinoline), 7.22 (t, 3JH-H = 7.8 Hz, 1H, quinoline), 7.74
(dd, 3JH-H = 8.4 Hz, 4JH-H = 1.5 Hz, 1H, quinoline), 9.12 (dd,
N-(2,6-Diisopropylphenyl)quinolin-8-amine (HL4). Following
the same procedure described for the formation of HL1, treat-
ment of 2,6-diisopropylaniline (2.13 g, 12 mmol), Pd(OAc)2 (22
mg, 0.10 mmol), NatOBu (1.44 g,15 mmol), 8-bromoquinoline
(2.08 g, 10 mmol), and bis[2-(diphenylphosphino)phenyl] ether
3JH-H = 4.8 Hz, JH-H = 1.5 Hz, 1H, quinoline). 13C NMR
4
(100 MHz, C6D6, 25 ꢀC): δ 4.26 (6C, SiMe3), 19.37 (2C,
o-NC6H2Me3), 21.40 (1C, p-NC6H2Me3), 25.10 (2C, THF),
41.44 (br, 2C, CH2SiMe3), 71.82 (2C, THF), 107.20, 111.38,
121.01 (3C, quinoline), 129.98 (2C, NC6H2Me3), 131.07, 131.18
(2C, quinoline), 133.32 (1C, NC6H2Me3), 134.91 (2C, NC6H2-
Me3), 140.12 (1C, quinoline), 141.49 (1C, NC6H2Me3), 146.19,
146.31, 153.33 (3C, quinoline). Anal. Calcd for C30H47ScN2Si2
(%): C, 65.18; H, 8.57; N, 5.07. Found: C, 64.39; H, 8.41;
N, 4.87.
(DPEphos, 80.8 mg, 0.15 mmol) gave HL4 (1.62 g, 53%). H
1
NMR (300 MHz, CDCl3, 25 ꢀC): δ 1.14 (d, 3JH-H = 10.8 Hz,
12H, CH(CH3)2), 3.22 (m, 2H, CH(CH3)2), 6.25 (d, 3JH-H = 7.8
Hz, 1H, quinoline), 7.05 (t, JH-H = 8.1 Hz, 1H, quinoline),
3
i
7.21-7.34 (m, 4H, NC6H3 Pr2, quinoline), 7.43 (q, 3JH-H = 4.2
Hz, 1H, quinoline), 7.53 (br s, 1H, NH), 8.11 (d, 3JH-H = 8.1
3
4
Hz, 1H, quinoline), 8.82 (dd, JH-H = 4.2 Hz, JH-H = 1.2
Hz,1H, quinoline). 13C NMR (75 MHz, CDCl3, 25 ꢀC): δ 23.19
(2C, CH(CH3)2), 24.73 (2C, CH(CH3)2), 28.33 (2C, CH(CH3)2),
L3Sc(CH2SiMe3)2(THF) (3). Following a similar procedure
to that described for the preparation of 1, the reaction of
Sc(CH2SiMe3)3(THF)2 (0.18 g, 0.4 mmol in 3 mL of hexane)
with equimolar HL3 (0.11 g, 0.4 mmol in 4 mL of hexane) gave 3
(0.19 g, 83%). 1H NMR (300 MHz, C6D6, 25 ꢀC): δ 0.20, 0.45
(AB, 2JH-H = 11.6 Hz, 4H, CH2SiMe3), 0.28 (s, 18H, SiMe3),
1.13 (br, 4H, THF), 1.22 (t, 3JH-H = 7.5 Hz, 6H, CH2CH3), 2.72
(m, 2H, CH2CH3), 2.95 (m, 2H,CH2CH3), 3.72 (br, 4H, THF),
6.17 (d, 3JH-H = 7.8 Hz, 1H, quinoline), 6.79 (d, 3JH-H = 7.8
i
106.11, 114.35, 121.36 (3C, quinoline), 123.81 (2C, NC6H3 Pr2),
127.37 (1C, NC6H3 Pr2), 127.60, 128.75, 135.26, 135.98 (4C,
i
i
quinoline), 137.66 (1C, NC6H3 Pr2), 144.67, 147.06 (2C,
i
quinoline), 147.85 (2C, NC6H3 Pr2).
N-Phenylquinolin-8-amine (HL5). Following the same proce-
dure described for the formation of HL1, treatment of aniline
(1.12 g, 12 mmol), Pd(OAc)2 (22 mg, 0.10 mmol), NatOBu
(1.44 g,15 mmol), 8-bromoquinoline (2.08 g, 10 mmol), and
bis[2-(diphenylphosphino)phenyl] ether (DPEphos, 80.8 mg,
0.15 mmol) gave HL5 (1.60 g, 73%). 1H NMR (300 MHz,
3
Hz, 1H, quinoline), 6.97 (q, JH-H = 4.8 Hz, 1H, quinoline),
7.19-7.29 (m, 3H, NC6H3Et2, quinoline), 7.74 (d, 3JH-H = 8.1
Hz, 1H, quinoline), 9.15 (d, 3JH-H = 4.8 Hz, 1H, quinoline). 13
C
3
NMR (100 MHz, C6D6, 25 ꢀC): δ 4.19 (6C, SiMe3), 15.36 (2C,
CH2CH3), 25.32 (2C, CH2CH3), 25.11 (2C, THF), 41.51 (br, 2C,
CH2SiMe3), 71.85 (2C, THF), 108.23, 111.40, 121.03 (3C,
quinoline), 125.00 (1C, NC6H3Et2), 126.75 (2C, NC6H3Et2),
130.75, 131.09, 140.16 (3C, quinoline), 140.72 (2C, NC6H3Et2),
141.30 (1C, NC6H3Et2), 146.21, 148.00, 154.21 (3C, quinoline).
Anal. Calcd for C31H49ScN2Si2 (%): C, 65.68; H, 8.71; N, 4.94.
Found: C, 64.72; H, 8.39; N, 4.71.
CDCl3, 25 ꢀC): δ 7.05 (s, 1H, JH-H = 6.3 Hz, NC6H5), 7.22
(d, 3JH-H = 8.1 Hz, 1H, quinoline), 7.35-7.45 (m, 6H, NC6H5,
3
quinoline), 7.45 (d, JH-H = 7.7 Hz, 1H, quinoline), 8.13 (d,
3JH-H = 8.4 Hz, 1H, quinoline), 8.30 (br s, 1H, NH), 8.79 (d,
3JH-H = 3.6 Hz, 1H, quinoline). 13C NMR (75 MHz, CDCl3,
25 ꢀC): δ 107.76, 116.45 (2C, quinoline), 119.99 (2C, NC6H5),
121.48 (1C, NC6H5), 122.04, 127.23, 128.81 (3C, quinoline),
129.27 (2C, NC6H5), 136.08 (1C, quinoline), 138.50 (1C, NC6-
H5), 140.21, 141.82, 147.20 (3C, quinoline).
L4Sc(CH2SiMe3)2(THF) (4). Following a similar procedure
to that described for the preparation of 1, the reaction of
Sc(CH2SiMe3)3(THF)2 (0.18 g, 0.4 mmol in 3 mL of hexane)
with equimolar HL4 (0.12 g, 0.4 mmol in 4 mL of hexane) gave 4
(0.18 g, 76%). 1H NMR (300 MHz, C6D6, 25 ꢀC): δ 0.16, 0.36
(AB, 2JH-H = 11.6 Hz, 4H, CH2SiMe3), 0.22 (s, 18H, SiMe3),
1.17 (br, 4H, THF), 1.14 (d, 6H, CH(CH3)2), 1.28 (d, 6H,
CH(CH3)2), 3.52 (m, 2H, CH(CH3)2), 3.70 (br, 4H, THF),
6.12 (d, 3JH-H = 7.8 Hz, 1H, quinoline), 6.73 (d, 3JH-H = 7.8
Preparation of the Complexes. L1Sc(CH2SiMe3)2(THF) (1).
To a hexane solution (3.0 mL) of Sc(CH2SiMe3)3(THF)2 (0.18 g,
0.4 mmol) was dropwise added an equivalent of HL1 (0.10 g, 0.4
mmol in 4 mL of hexane) at room temperature. The resulting red
solution was stirred for 20 min at room temperature and then
was concentrated to about 2 mL and cooled to -30 ꢀC for 12 h to
afford red crystalline solids, which were washed carefully with a
small amount of hexane (0.5 mL) to remove impurities and dried
in vacuo to give red powders of complex 1 (0.17 g, 81%). Red
crystals for X-ray analysis grew from a solution of hexane at
-30 ꢀC within 24 h. 1H NMR (300 MHz, C6D6, 25 ꢀC): δ 0.16,
3
Hz, 1H, quinoline), 6.91 (q, JH-H = 4.8 Hz, 1H, quinoline),
=
i
3
7.11-7.30 (m, 4H, NC6H3 Pr2, quinoline), 7.71 (dd, JH-H
7.4 Hz, 4JH-H = 1.5 Hz, 1H, quinoline), 9.16 (dd, 3JH-H = 4.8
2
4
0.42 (AB, JH-H = 11.3 Hz, 4H, CH2SiMe3), 0.27 (s, 18H,
Hz, JH-H = 1.5 Hz, 1H, quinoline). 13C NMR (100 MHz,
SiMe3), 1.08 (br, 4H, THF), 2.33 (s, 6H, o-NC6H3Me2), 3.69 (br,
C6D6, 25 ꢀC): δ 4.22 (6C, SiMe3), 24.70 (2C, CH(CH3)2), 25.39